Critical Reviews In Oncology Hematology

Critical Reviews In Oncology Hematology

肿瘤学血液学评论

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Critical Reviews In Oncology Hematology》是由Elsevier Ireland Ltd出版社于1983年创办的英文国际期刊(ISSN: 1040-8428,E-ISSN: 1879-0461),该期刊长期致力于血液学领域的创新研究,主要研究方向为医学-血液学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0880...%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比0.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在181篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Critical Reviews In Oncology Hematology审稿周期约为 偏慢,4-8周 约27.3周。该刊近年未被列入国际预警名单,年发文量约181篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 181 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
HEMATOLOGY 血液学 ONCOLOGY 肿瘤学
2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
HEMATOLOGY 血液学 ONCOLOGY 肿瘤学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q1 15 / 97

85.1%

学科:ONCOLOGY SCIE Q1 59 / 322

81.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 26 / 97

73.71%

学科:ONCOLOGY SCIE Q2 96 / 322

70.34%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:11 SJR:1.572 SNIP:1.396
学科类别 分区 排名 百分位
大类:Medicine 小类:Geriatrics and Gerontology Q1 8 / 116

93%

大类:Medicine 小类:Oncology Q1 49 / 404

87%

大类:Medicine 小类:Hematology Q1 20 / 137

85%

期刊发文

  • Rare histotypes of epithelial biliary tract tumors: A literature review

    Author: Sapuppo, Elena; Brunetti, Oronzo; Tessitore, Dalila; Brandi, Giovanni; Di Giovanni, Nicola; Fadda, Guido; Luchini, Claudio; Martini, Maurizio; Quaresmini, Davide; Russo, Antonio; Santarpia, Mariacarmela; Scarpa, Aldo; Scartozzi, Mario; Tuccari, Giovanni; Franchina, Tindara; Silvestris, Nicola

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103892

  • Changing patterns of neoadjuvant therapy for locally advanced rectal cancer: A narrative review

    Author: He, Weijing; Li, Qingguo; Li, Xinxiang

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103885

  • The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis

    Author: Liu, Hao; Li, Zhuoqun; Han, Xuan; Li, Zhujun; Zhao, Yan; Liu, Fenghua; Zhu, Ziyu; Lv, Yi; Liu, Zhijun; Zhang, Nana

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103893

  • HER2-low breast cancer: Novel detections and treatment advances

    Author: Wu, Yun; Zhong, Ruiqi; Ma, Fei

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103883

  • Exosomes in sarcoma: Prospects for clinical applications

    Author: Ye, Huali; Tan, Linyun; Tu, Chongqi; Min, Li

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103895

  • NTRK fusions in thyroid cancer: Pathology and clinical aspects

    Author: Ma, Yanhui; Zhang, Qi; Zhang, Kexin; Liang, Yunzi; Ren, Fangbing; Zhang, Jingwen; Kan, Chengxia; Han, Fang; Sun, Xiaodong

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 184, Issue , pp. -. DOI: 10.1016/j.critrevonc.2023.103957

  • Impact of age on the overall survival benefits of anti-EGFR-containing regimens in head and neck squamous cell carcinoma: A meta-analysis of randomized controlled trials

    Author: Yuguang Zhao, Wenhui Liu, Meiting Sun, Qiuli Miao, Yingmin Liu, Huimin Tian, Yapin Su, Fujun Han

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 39-46, DOI:10.1016/j.critrevonc.2019.01.017

  • The roles of EBV-encoded microRNAs in EBV-associated tumors

    Author: Min Dong, Jian-ning Chen, Jun-ting Huang, Li-ping Gong, Chun-kui Shao

    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 30-38, DOI:10.1016/j.critrevonc.2019.01.014